tiprankstipranks
Syndax Pharmaceuticals Inc (SNDX)
NASDAQ:SNDX
US Market

Syndax Pharmaceuticals (SNDX) Income Statement

Compare
656 Followers

Syndax Pharmaceuticals Income Statement

Last quarter (Q4 2024), Syndax Pharmaceuticals's total revenue was $7.68M, an increase of 1332.84% from the same quarter last year. In Q4, Syndax Pharmaceuticals's net income was $-94.17M. See Syndax Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 23.68M$ 0.00$ 0.00$ 139.71M$ 1.52M
Gross Profit
$ 22.85M$ -12.00K$ -454.00K$ 139.25M$ 1.52M
Operating Expenses
$ 362.53M$ 229.95M$ 151.76M$ 113.49M$ 72.94M
Depreciation and Amortization
$ 8.00K$ 12.00K$ 454.00K$ 456.00K$ 515.00K
EBITDA
$ -313.82M$ -229.94M$ -151.76M$ 27.28M$ -70.29M
Operating Income
$ -339.67M$ -229.95M$ -151.76M$ 26.22M$ -71.42M
Other Income/Expenses
$ 20.91M$ 20.59M$ 2.42M$ -1.29M$ -1.74M
Pretax Income
$ -318.76M$ -209.36M$ -149.34M$ 24.93M$ -73.16M
Net Income
$ -318.76M$ -209.36M$ -143.75M$ 24.93M$ -73.07M
Per Share Metrics
Basic EPS
$ -3.73$ -2.98$ -2.37$ 0.48$ -1.77
Diluted EPS
$ -3.73$ -2.98$ -2.37$ 0.46$ -1.77
Weighted Average Shares Outstanding
85.43M 70.26M 60.76M 52.06M 41.31M
Weighted Average Shares Outstanding (Diluted)
85.43M 70.37M 60.76M 53.62M 41.31M
Currency in USD

Syndax Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis